Germax Pharm Chemicals Co., Ltd

High quality, Best service,Reliable supplier

About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsApi Active Pharmaceutical Ingredient

Antiepileptic Drug Topiramate Powder CAS 97240-79-4 99% Purity

I'm Online Chat Now
Very happy to work with this company , they did their part ensure quick delivery, if you need something domestic don't go anywhere else ,great friendly people to do great business with

—— Jim Frank

Excellent quality and customer service , shipped fast with no delay other than extensive inspection here in the U.S . But not at fault of the supplier , the product is professionally packaged and i will definitely be looking forward to continued cooperation .

—— Thomas Paul

Our order was 100% pure after lab testing with quick delivery and professional service .Will order again .

—— Robert Kimlicka

Thank you ! Thanks for the quick response ! I receiveed the product safely ! Also thank you !

—— Brian Steward

This is a very good product .I will order more in the future , it got here U.S quickly , thanks . Dan

—— Dan Bedrock

Antiepileptic Drug Topiramate Powder CAS 97240-79-4 99% Purity

Antiepileptic Drug Topiramate Powder CAS 97240-79-4 99% Purity
Antiepileptic Drug Topiramate Powder CAS 97240-79-4 99% Purity

Large Image :  Antiepileptic Drug Topiramate Powder CAS 97240-79-4 99% Purity Get Best Price

Product Details:
Place of Origin: China
Brand Name: germax
Certification: GMP
Model Number: Topiramate
Payment & Shipping Terms:
Minimum Order Quantity: 1kg
Price: Negotiable
Packaging Details: 1kg/bag or 25kgs/drum
Delivery Time: within 3 days
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 500kgs/week
Detailed Product Description
Name: Topiramate Cas: 97240-79-4
Mf: C12H21NO8S Purity: 99%
Appearance: White Powder Package: 1kg/bag Or 25kgs/drum
High Light:

Antiepileptic Drug Topiramate Powder


97240-79-4 Topiramate Powder


99% Purity Topiramate Powder

Factory Supply Topiramate Antiepileptic Drug with Best Price CAS 97240-79-4 Topiramate 99%



Product name Topiramate
CAS NO 97240-79-4
MW 339.36
EINECS 200-659-6
Appearance White Powder
Usage 1. anticonvulsant, antimigraine, GABA-A agonist, AMP/kinate glutamate receptor antagonist, carbonic anhydrase inhibitor.
2. Used for the treatment and control of partial seizures and severe tonic-clonic (grand mal) seizures and also for the prevention of migraine headaches. In children it is also used for treatment of Lennox-Gastaut syndrome.

Topiramate Description:

Topiramate (the TPM) is a naturally existing monosaccharide D-fructose sulfide, and together with felbamate, lamotrigine and vigabatrin are current several broad-spectrum anti-epileptic drugs with relatively wide clinical application and can be used to control different types of epilepsy with excellent efficacy and pharmacokinetics.

This product is generally used for the adjuvant treatment of antiepileptic drugs and is effective in treating simple and complex seizures as well as systemic tonic-clonic seizures and can also be used for the treatment of infantile spasms. Features of this product include excellent long-term efficacy, no significant resistance as well as being able to be used alone for antiepileptic purpose.

But in cases of being applied to children or fast increase of the amount can cause cognitive impairment and neurotoxicity, and easy to trigger kidney stones.

Topiramate Ptoduct Application:

In 1980, scientists had first successfully synthesized topiramate in the laboratory. It had been applied to patients with epilepsy for the first time in 1986. In 1995, it was approved for entering into the market of UK for the first time. Its basic structure is fructopyranose sulfamate. Unlike other kinds of anti-epileptic drug, TPM has various kinds of anti-epileptic mechanisms including blocking the voltage-dependent sodium channels, enhancing the activity of GABA in the location of the γ- aminobutyric acid A (GABAA) receptor as well as blocking the activity of the AMPA glutamate receptor. In addition, there is still mild effect of carbonic anhydrase inhibitors.

Europe and the United States had conducted double-blind, placebo-controlled studies and demonstrated that the adjunctive therapy with topiramate has excellent efficacy, safety and is well tolerated in the treatment of various types of refractory epilepsy. Now it has begun with topiramate monotherapy and has also achieved good results with 62% of patients with epileptic seizures disappearing completely.



Contact Details
Germax Pharm Chemicals Co., Ltd

Contact Person: July

Tel: 25838890

Send your inquiry directly to us